Interim analysis of a phase II study of risk-adapted intravenous melphalan followed by adjuvant dexamethasone (D) and thalidomide (T) for newly diagnosed patients with systemic AL amyloidosis (AL) Meeting Abstract
| Authors: | Cohen, A. D.; Zhou, P.; Reich, L.; Fircanis, S.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Filippa, D. A.; Fleisher, M.; Comenzo, R. L. |
| Abstract Title: | Interim analysis of a phase II study of risk-adapted intravenous melphalan followed by adjuvant dexamethasone (D) and thalidomide (T) for newly diagnosed patients with systemic AL amyloidosis (AL) |
| Meeting Title: | 2005 BMT Tandem Meetings |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 11 |
| Issue: | 2 Suppl. 1 |
| Meeting Dates: | 2005 Feb 10-14 |
| Meeting Location: | Keystone, CO |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2005-02-01 |
| Start Page: | 7 |
| Language: | English |
| DOI: | 10.1016/j.bbmt.2004.12.020 |
| ACCESSION: | WOS:000227329000020 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract 19 - Oral presentations - "Source: Wos" |
